STING1 and neoplasm: Beyond high-contrast in vivo hypoxic tumor imaging, the hypoxia-triggered PTT/PDT attributes elicited by the probe jointly activated ICD and the cGAS-STING pathway to enhance tumor-specific immune response and mitigate immunological resistance.